Abstract:Lymph node (LN) metastasis at an early stage of cervical cancer is often an indicator of poor prognosis and is critical for subsequent adjuvant therapy. The current study aimed to identify aberrant gene signatures and biomarkers of metastasis for patients with cervical cancer. RNA-sequencing data of 132 LN negative (N0) and 60 LN positive (N1) cervical cancer samples obtained from The Cancer Genome Atlas database were analyzed. Differentially expressed genes were identified using R packages 'edgeR' and 'limma'. Kyoto Encyclopedia of Genes and Genomes pathway enrichment and Gene Set Enrichment Analysis (GSEA) were conducted. The GSE9750 dataset obtained from Gene Expression Omnibus was analyzed to identify genes that are persistently aberrantly expressed during the development of cervical cancer. The peroxisome proliferator-activated receptor (PPAR) signaling pathway was screened out to be significant during LN metastasis. In the two analyzed datasets, 11 genes were aberrantly expressed, while matrix metalloproteinase 1 (MMP1) was the only gene that was persistently overexpressed. Cell viability, wound healing and Transwell assays were performed to evaluate the effects of MMP1 knockdown in cervical cancer cell lines, and the expression of epithelial mesenchymal transition (EMT) markers was detected. Finally, the clinical significance of MMP1 was investigated. The current study identified that MMP1 was overexpressed and the PPAR signaling pathway was associated LN metastasis in patients with cervical cancer. Following knockdown of MMP1, the proliferation, migration and invasion of cervical cancer cell lines were weakened, the expression of epithelial marker E-cadherin was increased, and the expression of metastasis-associated gene vimentin was decreased. MMP1 was an independent prognostic factor for cervical cancer. The current study indicated that MMP1 has a key role in the regulation of cervical tumor growth and LN metastasis via EMT to a certain extent. The results suggest that MMP1 may be a biomarker for LN metastasis of cervical cancer, and further validation should be performed.

The Overexpression Membrane Type 1 Matrix Metalloproteinase Is Associated With The Progression And Prognosis In Breast Cancer

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

[Significance of Membrane Type-1 Matrix Metalloproteinase Expression in Breast Cancer].

The expression of tumor metastasis suppressor gene KAI1 and matrix metalloproteinase 2 in breast cancer tissues

Expression of Membrane Type 1-Matrix Metalloproteinase in Laryngeal Carcinoma

Expression of Membrane Type-2 Matrix Metalloproteinase in Gastric Cancer Tissues and Its Correlation with Prognosis

Overexpression of Membrane-Type 2 Matrix Metalloproteinase Induced by Hypoxia-Inducible Factor-1Α in Pancreatic Cancer: Implications for Tumor Progression and Prognosis.

MT2-MMP Expression Associates with Tumor Progression and Angiogenesis in Human Lung Cancer.

Expression and Significance of Membrane Type-1 Matrix Metalloproteinase and Matrix Metalloproteinase-2 in Human Glioma

Matrix Metalloproteinase-1 Expression in Breast Cancer and Cancer-Adjacent Tissues by Immunohistochemical Staining.

Expression of matrix metalloproteinase 1 in tissue of colon carcinoma and its clinical prognostic significance

Decreased Mt1-Mmp in Gastric Cancer Suppressed Cell Migration and Invasion Via Regulating Mmps and Emt

Matrix Metalloproteinase 1 Acts as an Independent Prognostic Biomarker Correlated with Immune Infiltration in Breast Cancer

Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients

Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model

Matrix Metalloproteinase Expressions Play Important role in Prediction of Ovarian Cancer Outcome

Expression of Membrane Type-1 Matrix Metalioproteinase in Invasive Hepatocellular Carcinoma

Identification and Validation of the Role of Matrix Metalloproteinase-1 in Cervical Cancer

Expression and Clinical Significance of Matrix Metalloproteinase-9 in Lymphatic Invasiveness and Metastasis of Breast Cancer.

Expression of MMP-9 protein and its mRNA in the tissues of breast cancer

Increased Mt2-Mmp Expression in Gastric Cancer Patients is Associated with Poor Prognosis